Letter to the Editor31P-MR spectroscopy in monozygotic twins discordant for schizophrenia or schizoaffective disorder
Section snippets
Role of funding source
Funding for this study was provided by DFG and EU grants; neither the DFG nor EU had further roles in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Contributors
Authors I.N., M.W., H.S., and S.S. designed the study and wrote the protocol. Authors I.N., K.L., R.M., R.R., A.G., J.R.R, and St.S. managed the literature searches and analyses. Authors I.N., K.L., and S.S. undertook the statistical analysis, and author I.N. wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
Conflict of interest
The authors declare that they have no relevant conflicts of interest that might influence the study design, data acquisition, interpretation, or other parts of this work.
Acknowledgment
We are grateful to all colleagues referring twin patients for this study, as well as all study participants. This work was partially supported by the EU as part of the EUTwinsS network study (RTN under FP6; PIs: H.S., M.W., and I.N.), where R. Maitra was a Marie Curie Fellow.
References (6)
- et al.
A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls
Biol. Psychiatry
(1999) - et al.
Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia
NeuroImage
(2007) - et al.
Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study
Mol. Psychiatry
(2003)